BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 23313547)

  • 21. LXRα is uniquely required for maximal reverse cholesterol transport and atheroprotection in ApoE-deficient mice.
    Hong C; Bradley MN; Rong X; Wang X; Wagner A; Grijalva V; Castellani LW; Salazar J; Realegeno S; Boyadjian R; Fogelman AM; Van Lenten BJ; Reddy ST; Lusis AJ; Tangirala RK; Tontonoz P
    J Lipid Res; 2012 Jun; 53(6):1126-33. PubMed ID: 22454476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telmisartan enhances cholesterol efflux from THP-1 macrophages by activating PPARgamma.
    Nakaya K; Ayaori M; Hisada T; Sawada S; Tanaka N; Iwamoto N; Ogura M; Yakushiji E; Kusuhara M; Nakamura H; Ohsuzu F
    J Atheroscler Thromb; 2007 Jun; 14(3):133-41. PubMed ID: 17587765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homocysteine accelerates atherosclerosis via inhibiting LXRα-mediated ABCA1/ABCG1-dependent cholesterol efflux from macrophages.
    Jin P; Bian Y; Wang K; Cong G; Yan R; Sha Y; Ma X; Zhou J; Yuan Z; Jia S
    Life Sci; 2018 Dec; 214():41-50. PubMed ID: 30393020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile.
    Hu X; Steffensen KR; Jiang ZY; Parini P; Gustafsson JÅ; Gåfvels M; Eggertsen G
    J Intern Med; 2012 Nov; 272(5):452-64. PubMed ID: 22329358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Liver X receptors mediate cholesterol efflux in mouse glomerular mesangial cells].
    Yu B; Wu J; Zhang XY; Chen LH; Yang GR; Wei MF; Xing CY; Guan YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):244-8. PubMed ID: 16778964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skeletal muscle as a target of LXR agonist after long-term treatment: focus on lipid homeostasis.
    Archer A; Laurencikiene J; Ahmed O; Steffensen KR; Parini P; Gustafsson JÅ; Korach-André M
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E494-502. PubMed ID: 24368671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144.
    Ramírez CM; Rotllan N; Vlassov AV; Dávalos A; Li M; Goedeke L; Aranda JF; Cirera-Salinas D; Araldi E; Salerno A; Wanschel A; Zavadil J; Castrillo A; Kim J; Suárez Y; Fernández-Hernando C
    Circ Res; 2013 Jun; 112(12):1592-601. PubMed ID: 23519695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LXR{beta} is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux.
    Hessvik NP; Boekschoten MV; Baltzersen MA; Kersten S; Xu X; Andersén H; Rustan AC; Thoresen GH
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E602-13. PubMed ID: 19996385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lycopene and the LXRα agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARγ-LXRα-ABCA1 pathway.
    Yang CM; Lu YL; Chen HY; Hu ML
    J Nutr Biochem; 2012 Sep; 23(9):1155-62. PubMed ID: 22137263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unsaturated fatty acids repress expression of ATP binding cassette transporter A1 and G1 in RAW 264.7 macrophages.
    Ku CS; Park Y; Coleman SL; Lee J
    J Nutr Biochem; 2012 Oct; 23(10):1271-6. PubMed ID: 22209005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
    Trasino SE; Kim YS; Wang TT
    Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue-specific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue.
    Ulven SM; Dalen KT; Gustafsson JA; Nebb HI
    J Lipid Res; 2004 Nov; 45(11):2052-62. PubMed ID: 15292368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE.
    Bradley MN; Hong C; Chen M; Joseph SB; Wilpitz DC; Wang X; Lusis AJ; Collins A; Hseuh WA; Collins JL; Tangirala RK; Tontonoz P
    J Clin Invest; 2007 Aug; 117(8):2337-46. PubMed ID: 17657314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of liver X receptor induces macrophage interleukin-5 expression.
    Chen Y; Duan Y; Kang Y; Yang X; Jiang M; Zhang L; Li G; Yin Z; Hu W; Dong P; Li X; Hajjar DP; Han J
    J Biol Chem; 2012 Dec; 287(52):43340-50. PubMed ID: 23150660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
    Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
    J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
    Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP
    Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent progress in liver X receptor-selective modulators.
    Ratni H; Wright MB
    Curr Opin Drug Discov Devel; 2010 Jul; 13(4):403-13. PubMed ID: 20597026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRα.
    Kiss E; Popovic Z; Bedke J; Wang S; Bonrouhi M; Gretz N; Stettner P; Teupser D; Thiery J; Porubsky S; Adams J; Gröne HJ
    Am J Pathol; 2011 Jul; 179(1):92-103. PubMed ID: 21703396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of liver-X-receptor α but not liver-X-receptor β protects against myocardial ischemia/reperfusion injury.
    He Q; Pu J; Yuan A; Lau WB; Gao E; Koch WJ; Ma XL; He B
    Circ Heart Fail; 2014 Nov; 7(6):1032-41. PubMed ID: 25277999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Decline of ATP-binding cassette transporter G1 expressions with a liver X receptor-independent pathway in patients with type 2 diabetes].
    Wang HJ; Zhao XS; Sun HY; Chen LF; Yan XW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Dec; 46(6):899-905. PubMed ID: 25512280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.